{"id":"NCT01191450","sponsor":"Eurofarma Laboratorios S.A.","briefTitle":"Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension","officialTitle":"A Study to Evaluate the Safety and Efficacy of Chlorthalidone in Combination With Amiloride as a Treatment for Elderly Patients With Arterial Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2013-08","completion":"2013-08","firstPosted":"2010-08-30","resultsPosted":"2025-06-12","lastUpdate":"2025-06-12"},"enrollment":246,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Arterial Hypertension"],"interventions":[{"type":"DRUG","name":"Chlorthalidone 25 mg + amiloride hydrochloride 5 mg","otherNames":["Diupress® (Eurofarma Laboratórios Ltda.)"]},{"type":"DRUG","name":"Higroton® Laboratório Novartis","otherNames":[]}],"arms":[{"label":"Higroton®","type":"ACTIVE_COMPARATOR"},{"label":"Diupress®","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the efficacy and safety of Chlorthalidone 25 mg + amiloride hydrochloride 5 mg association in the treatment of elderly patients with arterial hypertension.","primaryOutcome":{"measure":"Number of Subjects With Serum Potassium Levels Below 4.0 mEq/l at Visit 4","timeFrame":"Visit 4 (75 ± 3 days of V1)","effectByArm":[{"arm":"Diupress®","deltaMin":18,"sd":null},{"arm":"Higroton®","deltaMin":19,"sd":null}],"pValues":[]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":10,"countries":["Brazil"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":121},"commonTop":["Metabolism and Nutrition Disorders","Investigations","Vascular Disorders","General Disorders and Administration Site Conditions","Gastrointestinal Disorders"]}}